Cleared Traditional

K970344 - MDILOG, MODEL MDC-511

K970344 is an FDA 510(k) clearance for MDILOG, manufactured by Medtrak Technologies, Inc.. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 189-day FDA review.

K970344 · Medtrak Technologies, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1997
Decision
189d
Days
Class 2
Risk

K970344 is an FDA 510(k) clearance for the MDILOG, MODEL MDC-511. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Medtrak Technologies, Inc. (Lakewood, US). The FDA issued a Cleared decision on August 6, 1997 after a review of 189 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Medtrak Technologies, Inc. devices

FDA 510(k) Submission Details - K970344

510(k) Number K970344 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 29, 1997
Decision Date August 06, 1997
Days to Decision 189 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d slower than avg
Panel avg: 140d · This submission: 189d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 247
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K970344.
SODIUM CHLORIDE INHALATION SOLUTION, USP
K972466 · Holopack International, LP · Aug 1997
STERILE WATER FOR INHALATION, USP
K972467 · Holopack International, LP · Aug 1997
ICEL ULTRASONIC NEBULIZER MODELS PU 12000 AIR AND PU 12300 AIR
K972371 · Brasamerica Medical Equipment, Inc. · Aug 1997
PORT-NEB
K971933 · Medic-Aid , Ltd. · Aug 1997
HAND HELD MEDISPACER
K972237 · Thayer Medical Corp. · Jul 1997
MASTER NEB II
K970542 · Bremed Italia, S.R.L. · Jun 1997